SONNET BIOTHERAPEUTICS HOLDINGS, INC. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
SONNET BIOTHERAPEUTICS HOLDINGS, INC. reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of $165.59 thousand for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-16.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2025-12-16
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $99.47K.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-06-30 was -$309.94K, a 236.09% decline year-over-year.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-03-31 was -$49.37K, a 293.18% decline year-over-year.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2024-12-31 was $425.43K.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2025 was $165.59K.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2024 was -$2.24M, a 1066.25% decline from fiscal 2023.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2023 was $231.95K.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2025-09-30 | $99.47K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-16 | -$210.48K derived: sum of 2 quarters · filed 2025-12-16 | -$259.85K derived: sum of 3 quarters · filed 2025-12-16 | $165.59K 10-K · filed 2025-12-16 |
| 2025-06-30 | -$309.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-13 | -$359.31K derived: sum of 2 quarters · filed 2025-08-13 | $66.12K 10-Q · filed 2025-08-13 | -$140.88K derived: sum of 4 quarters · filed 2025-12-16 |
| 2025-03-31 | -$49.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-13 | $376.06K 10-Q · filed 2025-05-13 | $169.06K derived: sum of 3 quarters · filed 2025-12-16 | $396.81K derived: sum of 4 quarters · filed 2025-12-16 |
| 2024-12-31 | $425.43K 10-Q · filed 2025-02-13 | $218.43K derived: sum of 2 quarters · filed 2025-12-16 | $446.17K derived: sum of 3 quarters · filed 2025-12-16 | $471.73K derived: sum of 4 quarters · filed 2025-12-16 |
| 2024-09-30 | -$207.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-16 | $20.74K derived: sum of 2 quarters · filed 2025-12-16 | $46.30K derived: sum of 3 quarters · filed 2025-12-16 | -$2.24M 10-K · filed 2025-12-16 |
| 2024-06-30 | $227.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-13 | $253.30K derived: sum of 2 quarters · filed 2025-08-13 | -$2.03M 10-Q · filed 2025-08-13 | -$2.07M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $25.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-13 | -$2.26M 10-Q · filed 2025-05-13 | -$2.29M derived: sum of 3 quarters · filed 2025-05-13 | -$2.10M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$2.29M 10-Q · filed 2025-02-13 | -$2.32M derived: sum of 2 quarters · filed 2025-02-13 | -$2.13M derived: sum of 3 quarters · filed 2025-02-13 | |
| 2023-09-30 | -$32.92K derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-17 | $157.70K derived: sum of 2 quarters · filed 2024-12-17 | $231.95K 10-K · filed 2024-12-17 | |
| 2023-06-30 | $190.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-14 | $264.87K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $74.25K 10-Q · filed 2024-05-14 |